EUVIMEDEUVIMED entdecken
Kohortenstudie

Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study

Kamilla Koszorú, Anikó Kovács, Kende Lőrincz, Márta Medvecz, Miklós Sárdy

Indian Journal of Dermatology, Venereology and Leprology · 2022

DOI: 10.25259/ijdvl_1111_2021 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Kamilla Koszorú und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Lichen Planus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are various topical and systemic treatment options for the management of lichen planus. However, it is often difficult to achieve long-term disease control and many of the common therapies may be associated with unwanted side effects.

Aims

To evaluate the effectiveness of 8 mg oral methylprednisolone administered daily in lichen planus by the analysis of medical records.

Methods

In this retrospective cohort study, we compared the rates of improvement between two groups of patients. The first group received 8 mg oral methylprednisolone daily for at least one month. In the second group, patients with similar parameters to the first group (age, sex, disease manifestation) but without systemic glucocorticoid therapy were included. Fisher’s exact test was used to compare the rates of remission in the two groups.

Results

In the daily oral methylprednisolone ( n = 24) and no systemic corticosteroids ( n = 16) groups, 23 (95.8%) and 6 (37.5%) patients achieved partial or complete remission, respectively. The frequency of improvement was significantly higher in patients who received oral methylprednisolone ( P < 0.0001).

Limitations

Limitations of this study include its retrospective design and the relatively small sample size.

Conclusion

Low dose oral glucocorticoid therapy may be an effective option for the systemic treatment of lichen planus. Based on our results and previous studies, instead of higher doses, longer therapy duration with low doses should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lichen Planus, OralLichen PlanusHumansGlucocorticoidsRetrospective StudiesMethylprednisolone

Stichwörter der Autor:innen

Lichen planuscorticosteroidsglucocorticoidsoral lichen planussystemic treatment

Substanzen

GlucocorticoidsMethylprednisolone

Autor:innen und Institutionen

  • Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary.

Zitieren

APA

Koszorú, K., Kovács, A., Lőrincz, K., Medvecz, M., & Sárdy, M. (2022). Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_1111_2021

Vancouver

Koszorú K, Kovács A, Lőrincz K, Medvecz M, Sárdy M. Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_1111_2021

BibTeX
@article{Koszor2022,
  author = {Koszorú, Kamilla and Kovács, Anikó and Lőrincz, Kende and Medvecz, Márta and Sárdy, Miklós},
  title = {Low dose oral glucocorticoid therapy in lichen planus: A retrospective cohort study},
  journal = {Indian Journal of Dermatology, Venereology and Leprology},
  year = {2022},
  doi = {10.25259/ijdvl_1111_2021}
}
Kostenlos starten →